These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17011883)

  • 21. RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA.
    Shimokawa S; Murakami Y; Fujiwara K; Funatsu J; Nakatake S; Koyanagi Y; Akiyama M; Yoshida N; Takeda A; Ikeda Y; Sonoda KH
    Retina; 2022 Jan; 42(1):168-173. PubMed ID: 34393209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
    Huang Q; Chen R; Lin X; Xiang Z
    PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRB1-Related Maculopathy With Cystoid Macular Edema.
    Wolfson Y; Applegate CD; Strauss RW; Han IC; Scholl HP
    JAMA Ophthalmol; 2015 Nov; 133(11):1357-60. PubMed ID: 26312378
    [No Abstract]   [Full Text] [Related]  

  • 24. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.
    Schaal Y; Hondur AM; Tezel TH
    Can J Ophthalmol; 2016 Aug; 51(4):e113-e115. PubMed ID: 27521675
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A; Fishman GA
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa.
    Oishi A; Otani A; Sasahara M; Kojima H; Nakamura H; Kurimoto M; Yoshimura N
    Eye (Lond); 2009 Jun; 23(6):1411-6. PubMed ID: 18724276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical particularities in an atypical case of retinitis pigmentosa.
    Horia ST; Bogdana T; Suvac E
    Rom J Ophthalmol; 2016; 60(1):43-6. PubMed ID: 27220233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination.
    Hajali M; Fishman GA
    Eye (Lond); 2009 Apr; 23(4):915-9. PubMed ID: 18425064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinitis pigmentosa and bilateral cystoid macular oedema in a patient heterozygous for the RIM1 mutation previously associated with cone-rod dystrophy 7.
    Warwick AN; Shawkat F; Lotery AJ
    Ophthalmic Genet; 2017; 38(2):178-182. PubMed ID: 27176872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry.
    Remky A; Weber A; Arend O; Sponsel WE
    Acta Ophthalmol Scand; 2005 Apr; 83(2):154-60. PubMed ID: 15799725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene.
    Cordovez JA; Traboulsi EI; Capasso JE; Sadagopan KA; Ganesh A; Rychwalski PJ; Neely KA; Brodie SE; Levin AV
    Ophthalmic Genet; 2015; 36(3):257-64. PubMed ID: 24512366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review.
    Bakthavatchalam M; Lai FHP; Rong SS; Ng DS; Brelen ME
    Surv Ophthalmol; 2018; 63(3):329-339. PubMed ID: 28987613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.
    Kim DG; Yoon CK; Kim HW; Lee SJ
    Can J Ophthalmol; 2018 Jun; 53(3):e103-e107. PubMed ID: 29784170
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.
    Genead MA; McAnany JJ; Fishman GA
    Retina; 2012 Apr; 32(4):826-33. PubMed ID: 21886018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cystic macular lesions in hereditary retinal dystrophies.
    Salvatore S; Fishman GA; Genead MA
    Surv Ophthalmol; 2013; 58(6):560-84. PubMed ID: 24160730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystoid macular oedema after selective laser trabeculoplasty.
    Wechsler DZ; Wechsler IB
    Eye (Lond); 2010 Jun; 24(6):1113. PubMed ID: 19816519
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome.
    Genead MA; Fishman GA; McAnany JJ
    Doc Ophthalmol; 2010 Dec; 121(3):231-40. PubMed ID: 20842519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.